» Articles » PMID: 36998052

PSMD2 Contributes to the Progression of Esophageal Squamous Cell Carcinoma by Repressing Autophagy

Overview
Journal Cell Biosci
Publisher Biomed Central
Specialty Biology
Date 2023 Mar 30
PMID 36998052
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The ubiquitin-proteasome and autophagy-lysosomal systems collaborate in regulating the levels of intracellular proteins. Dysregulation of protein homeostasis is a central feature of malignancy. The gene encoding 26S proteasome non-ATPase regulatory subunit 2 (PSMD2) of the ubiquitin-proteasome system is an oncogene in various types of cancer. However, the detailed role of PSMD2 in autophagy and its relationship to tumorigenesis in esophageal squamous cell carcinoma (ESCC) remain unknown. In the present study, we have investigated the tumor-promoting roles of PSMD2 in the context of autophagy in ESCC.

Methods: Molecular approaches including DAPgreen staining, 5-Ethynyl-2'-deoxyuridine (EdU), cell counting kit 8 (CCK8), colony formation, transwell assays, and cell transfection, xenograft model, immunoblotting and Immunohistochemical analysis were used to investigate the roles of PSMD2 in ESCC cells. Data-independent acquisition (DIA) quantification proteomics analysis and rescue experiments were used to study the roles of PSMD2 in ESCC cells.

Results: We demonstrate that the overexpression of PSMD2 promotes ESCC cell growth by inhibiting autophagy and is correlated with tumor progression and poor prognosis of ESCC patients. DIA quantification proteomics analysis shows a significant positive correlation between argininosuccinate synthase 1 (ASS1) and PSMD2 levels in ESCC tumors. Further studies indicate that PSMD2 activates the mTOR pathway by upregulating ASS1 to inhibit autophagy.

Conclusions: PSMD2 plays an important role in repressing autophagy in ESCC, and represents a promising biomarker to predict prognosis and a therapeutic target of ESCC patients.

Citing Articles

Integrating single-cell RNA-seq and bulk RNA-seq to construct a neutrophil prognostic model for predicting prognosis and immune response in oral squamous cell carcinoma.

Wang J, Cui Z, Song Q, Yang K, Chen Y, Peng S Hum Genomics. 2024; 18(1):140.

PMID: 39726033 PMC: 11670365. DOI: 10.1186/s40246-024-00712-7.


PHAX enhanced LIN28B-mediated PBX3 mRNA stability to promote esophageal cancer development.

Peng J, Lv L, Zhou Y, Wang X, Hu C Cancer Sci. 2024; 116(3):808-823.

PMID: 39668567 PMC: 11875786. DOI: 10.1111/cas.16420.


PSMD2 overexpression as a biomarker for resistance and prognosis in renal cell carcinoma treated with immune checkpoint and tyrosine kinase inhibitors.

Xu X, Wang J, Wang Y, Zhu Y, Wang J, Guo J Cell Oncol (Dordr). 2024; 47(5):1943-1956.

PMID: 39222176 DOI: 10.1007/s13402-024-00977-z.


Metabolic reprogramming in esophageal squamous cell carcinoma.

Wang Z, Sun X, Li Z, Yu H, Li W, Xu Y Front Pharmacol. 2024; 15:1423629.

PMID: 38989149 PMC: 11233760. DOI: 10.3389/fphar.2024.1423629.

References
1.
Lee I, Kawai Y, Fergusson M, Rovira I, Bishop A, Motoyama N . Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress. Science. 2012; 336(6078):225-8. PMC: 4721513. DOI: 10.1126/science.1218395. View

2.
Kim J, Hu Z, Cai L, Li K, Choi E, Faubert B . CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells. Nature. 2017; 546(7656):168-172. PMC: 5472349. DOI: 10.1038/nature22359. View

3.
Cao Q, You X, Xu L, Wang L, Chen Y . PAQR3 suppresses the growth of non-small cell lung cancer cells via modulation of EGFR-mediated autophagy. Autophagy. 2019; 16(7):1236-1247. PMC: 7469495. DOI: 10.1080/15548627.2019.1659654. View

4.
Pandey U, Nie Z, Batlevi Y, McCray B, Ritson G, Nedelsky N . HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature. 2007; 447(7146):859-63. DOI: 10.1038/nature05853. View

5.
Kageyama S, Sou Y, Uemura T, Kametaka S, Saito T, Ishimura R . Proteasome dysfunction activates autophagy and the Keap1-Nrf2 pathway. J Biol Chem. 2014; 289(36):24944-55. PMC: 4155663. DOI: 10.1074/jbc.M114.580357. View